dr. lopes discusses steroid side effects in lung cancer management
Published 6 years ago • 779 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:34
dr. lopes discusses the importance of addressing financial toxicity in lung cancer
-
1:11
dr. lopes on the rationale to stop immunotherapy after 2 years in lung cancer
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:12
dr. lopes on standard durations of checkpoint inhibition in metastatic lung cancer
-
0:41
dr. evans on managing side effects in lung cancer patients
-
3:13
dr. ramalingam on side effects associated with immunotherapy in lung cancer
-
2:30
dr. lopes on the keynote-042 results of frontline pembrolizumab in nsclc
-
2:00
marianne davies on managing immunotherapy side effects in lung cancer
-
2:35
dr. naidoo discusses the management of immune-related adverse events in lung cancer
-
2:05
dr. borghaei on the management of immune-related side effects in lung cancer
-
2:10
dr. pennell on unique treatment-related toxicities in lung cancer
-
1:19
dr. gieschen on the side effects of radiation therapy in nsclc
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
4:47
side effect management in advanced lung cancer
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
7:35
asco 2018 - will taking mod to high dose steroids affect lung cancer pts on immunotherapy?
-
4:03
managing toxicity in immunotherapy for lung cancer
-
5:35
covid-19 and cancer patient care: a lung cancer specialist’s experience | gilberto lopes
-
0:46
marianne davies discusses managing immunotherapy side effects